🔎 Trials Near Me

Home › Mga Sakit ng Neurologic › Florida

Pag-aaral pangklinika para sa Mga Sakit ng Neurologic sa Florida

14 pag-aaral para sa Mga Sakit ng Neurologic ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Brandon, Florida, Brandon
  • Miami, Florida, Miami
  • Miami, Florida, Miami
  • at 5 pa
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07598708

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Boca Raton
  • Clinical Site, Deerfield Beach
  • Clinical Site, Doral
  • at 11 pa
Nagre-recruitPhase 2
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06887192

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • JEM Research Institute, Atlantis
  • VIN - Aventura, Aventura
  • Brain Matters Research, Delray Beach
  • at 10 pa
Nagre-recruitPhase 2
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589595

Product Surveillance Registry

  • Bradenton
  • Clearwater
  • Davie
  • at 7 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2026 · NCT01524276

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #065, Altamonte Springs
  • Vima Site #054, Aventura
  • Vima Site #008, Miami
  • at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07804615

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Hollywood
  • Clinical Site, Hollywood
  • Clinical Site, Miami
  • at 2 pa
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07459647

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • K2 Medical Research, LLC, Maitland
  • Charter Research, LLC, The Villages
Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06297590

Rett Syndrome Registry

  • Nicklaus Children's Hospital, Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 99 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT05432349

Neurologic Stem Cell Treatment Study

  • MD Stem Cells, Coral Springs
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT02795052

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

  • Mayo Clinic, Jacksonville
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT07543367

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Maitland
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Stuart
Nagre-recruitPhase 2
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

  • North Florida/South Georgia Veterans Health System, Gainesville
  • Brooks Rehabilitation, Jacksonville
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update May 6, 2025 · NCT04460872

Investigating Health Impacts of Exposure to Harmful Algal Blooms

  • The Roskamp Institute, Sarasota
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2025 · NCT06883227

The Lake Nona Life Project

  • Lake Nona Institute, Orlando
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT02533804

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.